The estimated Net Worth of Yi Ching Yau is at least $182 Tausend dollars as of 16 November 2020. Ms Yau owns over 5,493 units of BridgeBio Pharma Inc stock worth over $181,543 and over the last 5 years she sold BBIO stock worth over $0.
Ms has made over 2 trades of the BridgeBio Pharma Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 5,493 units of BBIO stock worth $153,749 on 16 November 2020.
The largest trade she's ever made was exercising 5,493 units of BridgeBio Pharma Inc stock on 16 November 2020 worth over $153,749. On average, Ms trades about 982 units every 15 days since 2019. As of 16 November 2020 she still owns at least 6,486 units of BridgeBio Pharma Inc stock.
You can see the complete history of Ms Yau stock trades at the bottom of the page.
Yi Ching Yau is the Chief Accounting Officer at BridgeBio Pharma Inc.
Yi's mailing address filed with the SEC is 835 INDUSTRIAL ROAD, SUITE 600, SAN CARLOS, CA, 94070.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over $409,396,563 worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth $209,241,115 . The most active insiders traders include Global Investors Lp Viking ..., Andrew Lo und Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,173,197. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth $1,554,481.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: